Intangible Assets and Royalty Agreement (Details) (USD $)	12 Months Ended
	Dec. 31, 2012		Dec. 31, 2011
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Value	$ 17,526,000		$ 17,526,000
Impairment Adjustment	(1,798,495)
Accumulated Amortization	(4,848,756)		(3,468,515)
Net carrying value, Total	10,878,749		14,057,485
Acquisition price, one-time license fee	100,000
Shares issued for intangibles (in shares)	1,120,000
Value of shares issued for intangibles	896,000
Maximum time of approval	30 days
Contingent payments to licensor	200,000
Contingent royalty to be paid to licensor (in hundredths)	3.00%
Annual royalty payment	50,000
Acquisition price of asset, shares issued (in shares)	400,000
Acquisition of asset, value of shares issued	2,596,000
Number of shares issuable upon meeting certain milestones (in shares)	600,000
Contingent payments to licensor, shares issued	100,000
Contingent payment to licensor, value of shares issued	71,000
Indefinite-lived Intangible Assets [Line Items]
Impairment Adjustment	(1,798,495)
Intangible assets, gross carrying value	18,559,000		18,559,000
Accumulated Amortization	(4,848,756)		(3,468,515)
Intangible assets, net carrying value	11,911,749		15,090,485
Estimated future amortization expense [Abstract]
2013	1,050,380
2014	1,046,047
2015	1,022,651
2016	976,998
Thereafter	6,782,673
Net carrying value, Total	10,878,749		14,057,485
Trade names and trademarks [Member]
Indefinite-lived Intangible Assets [Line Items]
Weighted average useful life	indefinite
Gross Carrying Value	1,008,000		1,008,000
Accumulated Amortization	0		0
Net Carrying Value	1,008,000		1,008,000
In process research and development, liquid [Member]
Indefinite-lived Intangible Assets [Line Items]
Weighted average useful life	indefinite	[1]
In process research and development, other [Member]
Indefinite-lived Intangible Assets [Line Items]
Weighted average useful life	indefinite
Gross Carrying Value	25,000		25,000
Accumulated Amortization	0		0
Net Carrying Value	25,000		25,000
License-Shriners Hsp for Children & USF Research [Member]
Finite-Lived Intangible Assets [Line Items]
Weighted Average Amortization Lives	10 years
Gross Carrying Value	996,000		996,000
Impairment Adjustment	0
Accumulated Amortization	(587,633)		(488,033)
Net carrying value, Total	408,367		507,967
Estimated future amortization expense [Abstract]
Net carrying value, Total	408,367		507,967
License - SaluMedica LLC Spine Repair [Member]
Finite-Lived Intangible Assets [Line Items]
Weighted Average Amortization Lives	10 years
Gross Carrying Value	2,399,000		2,399,000
Impairment Adjustment	(851,676)
Accumulated Amortization	(1,547,324)		(1,313,573)
Net carrying value, Total	0		1,085,427
Estimated future amortization expense [Abstract]
Net carrying value, Total	0		1,085,427
License - Polyvinyl Alcohol Cryogel [Member]
Finite-Lived Intangible Assets [Line Items]
Weighted Average Amortization Lives	10 years
Gross Carrying Value	2,667,000		2,667,000
Impairment Adjustment	(946,819)
Accumulated Amortization	(1,223,561)		(998,932)
Net carrying value, Total	496,620		1,668,068
Estimated future amortization expense [Abstract]
Net carrying value, Total	496,620		1,668,068
Customer Relationships [Member]
Finite-Lived Intangible Assets [Line Items]
Weighted Average Amortization Lives	14 years
Gross Carrying Value	3,520,000		3,520,000
Accumulated Amortization	(502,857)		(251,429)
Net carrying value, Total	3,017,143		3,268,571
Estimated future amortization expense [Abstract]
Net carrying value, Total	3,017,143		3,268,571
Supplier Relationships [Member]
Finite-Lived Intangible Assets [Line Items]
Weighted Average Amortization Lives	14 years
Gross Carrying Value	241,000		241,000
Accumulated Amortization	(34,429)		(17,215)
Net carrying value, Total	206,571		223,785
Estimated future amortization expense [Abstract]
Net carrying value, Total	206,571		223,785
Patents and Know-How [Member]
Finite-Lived Intangible Assets [Line Items]
Weighted Average Amortization Lives	14 years
Gross Carrying Value	5,530,000		5,530,000
Accumulated Amortization	(790,000)		(395,000)
Net carrying value, Total	4,740,000		5,135,000
Estimated future amortization expense [Abstract]
Net carrying value, Total	4,740,000		5,135,000
Micronized Processing Know-How [Member]
Finite-Lived Intangible Assets [Line Items]
Weighted Average Amortization Lives	14 years
Gross Carrying Value	2,160,000		2,160,000
Accumulated Amortization	(154,286)		0
Net carrying value, Total	2,005,714		2,160,000
Estimated future amortization expense [Abstract]
Net carrying value, Total	2,005,714		2,160,000
Licenses and Permits [Member]
Finite-Lived Intangible Assets [Line Items]
Weighted Average Amortization Lives	3 years
Gross Carrying Value	13,000		13,000
Accumulated Amortization	(8,667)		(4,333)
Net carrying value, Total	4,333		8,667
Estimated future amortization expense [Abstract]
Net carrying value, Total	$ 4,333		$ 8,667

[1] AmnioFix injectable was launched in 2012 with amortization recorded over its expected useful life.